Stocks News

LAST PRICE
45.8700
TODAY'S CHANGE (%)
Trending Down-0.8000 (-1.7142%)

Bid / Lots
44.0100/ 1
Ask / Lots
46.5300/ 1
Open / Previous Close
46.0400 / 46.6700
Day Range
Low 45.5100
High 46.4250
52 Week Range
Low 30.1800
High 53.0500
Volume
321,674
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 24, 2024
- Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024, from 8:30AM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  8:30AM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  Companies Mentioned: VCEL
- Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024, from 8:30AM ET on Wednesday Apr 24, 2024 by Dow Jones
  8:30AM ET on Wednesday Apr 24, 2024 by Dow Jones
  Companies Mentioned: VCEL
  
  Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
  
  CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its first-quarter 2024 financial results on Wednesday, May 8, 2024. Vericel's management will host a conference call and webcast at 8:30 a.m. (ET) to discuss its financial results and business highlights.
Apr 19, 2024
- Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing, from 4:14PM ET on Friday Apr 19, 2024 by MT Newswires
  4:14PM ET on Friday Apr 19, 2024 by MT Newswires
  Companies Mentioned: VCEL
  04:14 PM EDT, 04/19/2024 (MT Newswires) -- Dominick Colangelo, Director, President and CEO, on April 17, 2024, sold 35,000 shares in Vericel (VCEL) for $1,593,550. Following the Form 4 filing with the SEC, Colangelo has control over a total of 195,3...

Today
- TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update, from 30 minutes ago by GlobeNewswire
  30 minutes ago by GlobeNewswire
  Companies Mentioned: TGTX
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, TBNK, from 3 hours ago by Accesswire
  3 hours ago by Accesswire
  Companies Mentioned: HTLF, TBNK, UMBF, DCPH
- Kuehn Law Encourages UMBF, HTLF, TBNK, and DCPH Investors to Contact Law Firm, from 4 hours ago by GlobeNewswire
  4 hours ago by GlobeNewswire
  Companies Mentioned: HTLF, TBNK, UMBF, DCPH
- Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target is $26, from 10 hours ago by MT Newswires
  10 hours ago by MT Newswires
  Companies Mentioned: DCPH
- Leerink Downgrades Deciphera Pharmaceuticals to Market Perform, Price Target at $25.60, from 10 hours ago by MT Newswires
  10 hours ago by MT Newswires
  Companies Mentioned: DCPH
- JMP Downgrades Deciphera Pharmaceuticals to Market Perform, from 10 hours ago by MT Newswires
  10 hours ago by MT Newswires
  Companies Mentioned: DCPH
Yesterday
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, HCP, from 21 hours ago by GlobeNewswire
  21 hours ago by GlobeNewswire
  Companies Mentioned: HTLF, DCPH, HCP
- INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPH, from 23 hours ago by PR Newswire
  23 hours ago by PR Newswire
  Companies Mentioned: DCPH
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HashiCorp Inc. (Nasdaq - HCP), Heartland Financial, USA Inc. (Nasdaq - HTLF), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq - TBNK), from 5:17PM ET on Monday Apr 29, 2024 by GlobeNewswire
  5:17PM ET on Monday Apr 29, 2024 by GlobeNewswire
  Companies Mentioned: HTLF, TBNK, HOPE, UMBF, DCPH, HCP
- US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week, from 4:10PM ET on Monday Apr 29, 2024 by MT Newswires
  4:10PM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: HTLF, LLY, UMBF, AAPL, DCPH, AMZN, DPZ

Vericel Corp
NASDAQ:VCELUnited States

Search Criteria

Apr 24, 2024

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024, from 8:30AM ET on Wednesday Apr 24, 2024 by GlobeNewswire

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024, from 8:30AM ET on Wednesday Apr 24, 2024 by Dow Jones

Apr 19, 2024

Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing, from 4:14PM ET on Friday Apr 19, 2024 by MT Newswires

Peers Headlines

Today

TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update, from 30 minutes ago by GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, TBNK, from 3 hours ago by Accesswire

Kuehn Law Encourages UMBF, HTLF, TBNK, and DCPH Investors to Contact Law Firm, from 4 hours ago by GlobeNewswire

Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target is $26, from 10 hours ago by MT Newswires

Leerink Downgrades Deciphera Pharmaceuticals to Market Perform, Price Target at $25.60, from 10 hours ago by MT Newswires

JMP Downgrades Deciphera Pharmaceuticals to Market Perform, from 10 hours ago by MT Newswires

Yesterday

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, HCP, from 21 hours ago by GlobeNewswire

INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPH, from 23 hours ago by PR Newswire

US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week, from 4:10PM ET on Monday Apr 29, 2024 by MT Newswires